Scheepers C, Richardson SI, Moyo-Gwete T, Moore PL. Antibody class-switching as a strategy to improve HIV-1 neutralization. Trends Mol Med. 2022;28(11):979-88. https://www.cell.com/trends/molecular-medicine/pdf/S1471-4914(22)00215-5.pdf
Antibody class-switching as a strategy to improve HIV-1 neutralization.
By Peter Matlawa|2023-03-01T09:11:52+02:00March 1, 2023|2022: July to September|Comments Off on Antibody class-switching as a strategy to improve HIV-1 neutralization.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys(®) cortisol II assay: a pilot study.